ScanlanKemperBard Companies LLC
07/14/2022 | Press release | Archived content
Twist's Biotech $100M investment in Oregon is on track at Parkworks
The South San Francisco-based maker of synthetic DNA plans to be in operation in the Portland area by January.
ScanlanKemperBard Companies LLC published this content on July 14, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 20, 2026 at 10:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]